Eli Lilly said it plans to build three new plants in the U.S. to make the key ingredients used in pharmaceuticals, part of a ...
Eli Lilly & Co. will spend at least $27 billion to build four US manufacturing plants, the latest company to brace for the ...
Eli Lilly is doubling its U.S. manufacturing investment since 2020 as it seeks to produce more drugs domestically. Its latest ...
At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine ...
Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, announced Wednesday that it plans to invest $27 ...
A new wave of biotech venture capital firms, led by younger investors, is reshaping the industry with fresh strategies and a ...
Pharmaceutical giant Eli Lilly announced Wednesday that it plans to invest roughly $27 billion in United States manufacturing ...
The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...
Eli Lilly plans to spend at least $27bn to build four new manufacturing plants in the United States, the drugmaker has said ...
The new plants will be built over the next five years, and are expected to create more than 3,000 jobs for skilled workers.
At the four new sites, Lilly expects to create more than 3,000 jobs for engineers, scientists, operations personnel, and lab technicians.
The news comes amid the possibility that President Trump imposes a 25% tariff on pharmaceuticals, which could encourage manufacturers to begin reshoring their services.